TinyGemsBreaks Archive - Page 32 of 148

TuesdayFeb 25, 2025 2:29 pm

TinyGemsBreaks – Consumer Automotive Finance Inc. (CAFI) Initiates ‘Shareholder-Centric Strategy’ to Retire 246 Million Common Shares

Consumer Automotive Finance (OTC: CAFI), a dynamic leader in the sports supplement, fitness equipment, and health and wellness industries, today announced the finalization of an agreement to retire 246 million of its issued and outstanding common shares. “This landmark share retirement exemplifies our management team's resolute focus on creating enduring value for our shareholders,” said Brandon Spikes, chairman of Consumer Automotive Finance. “By reducing our outstanding shares by 246 million, we are not only enhancing the intrinsic value of each remaining share but also signaling our confidence in CAFI's growth trajectory and long-term profitability. This is a deliberate, shareholder-centric strategy…

MondayFeb 24, 2025 1:55 pm

TinyGemsBreaks – SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), Viridi Collaborate on Hybrid Generation Solar Project in Buffalo

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), an independent renewable and clean energy project developer and owner focusing on distributed and community solar projects in Canada and the U.S., was featured in an article published by Buffalo Business First. The piece highlights SolarBank’s collaboration with Viridi on a proposed $7 billion solar project at a former landfill in South Buffalo, which would include 3.06 megawatts of solar generation and 1.2 megawatt-hours of battery storage. While relatively rare, these hybrid generation projects are becoming more common according to Matthew McGregor, senior developer of U.S.…

FridayFeb 21, 2025 8:30 am

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Present at European Life Sciences CEO Forum

CNS Pharmaceuticals (NASDAQ: CNSP) announced that CEO John Climaco will present at the 18th Annual European Life Sciences CEO Forum in Zurich on Feb. 26, 2025, at 3:20 p.m. CET / 9:20 a.m. EST; management will also be available for one-on-one meetings with registered investors, and a video webcast of the presentation will be accessible on-demand through the conference presenters portal. To view the full press release, visit https://ibn.fm/XEi92 About CNS Pharmaceuticals Inc. CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central…

ThursdayFeb 20, 2025 1:01 pm

TinyGemsBreaks – Consumer Automotive Finance Inc. (CAFI) Finalizes Steps for Rebrand to Fifty 1 Labs, Inc. (OTC: FITY)

Consumer Automotive Finance (CAFI) announced it has successfully addressed all final inquiries from FINRA regarding its corporate name and ticker change to Fifty 1 Labs, Inc. (OTC: FITY), expected to be completed within 30 days. Led by former NFL player Brandon Spikes, Fifty 1 Labs focuses on sports nutrition, performance training, and tactical gear, including its Drago Knives and The Quickness brands. The rebrand aligns with the company’s strategic expansion, aiming to enhance visibility and shareholder value in the sports and lifestyle markets. To view the full press release, visit https://ibn.fm/XKCQn About Fifty 1 Labs, Inc. Consumer Automotive Finance, Inc.…

ThursdayFeb 20, 2025 8:30 am

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights 2025 Outlook at Virtual Investor Conference

CNS Pharmaceuticals (NASDAQ: CNSP) announced its participation in the Virtual Investor Top 5 for ‘25 On-Demand Conference, where CEO John Climaco outlined five key reasons for investors and industry peers to follow the company in 2025. The presentation focused on CNS Pharmaceuticals’ advancements in developing treatments for primary and metastatic brain and central nervous system cancers, emphasizing its strategic initiatives and clinical progress for the year ahead. To view the full press release, visit https://ibn.fm/wXsRi About CNS Pharmaceuticals Inc. CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic…

TuesdayFeb 18, 2025 12:47 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present at 6th Glioblastoma Drug Development Summit

CNS Pharmaceuticals (NASDAQ: CNSP) announced its participation in the 6th Glioblastoma Drug Development Summit, taking place Feb. 18-20, 2025, in Boston. Chief Medical Officer Dr. Sandra Silberman will present on Feb. 20 at 10:45 a.m. ET, discussing novel formulations of anthracyclines and taxanes designed to cross the blood-brain barrier. The company’s lead candidate, Berubicin, has completed patient enrollment in a pivotal study against glioblastoma, with primary analysis data expected in the first half of 2025. CNS Pharmaceuticals is also advancing TPI 287 and plans to engage with the FDA on trial design. Berubicin has received Fast Track and Orphan Drug…

TuesdayFeb 18, 2025 8:30 am

TinyGemsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Offers On-Premises Quantum Computing Systems for Research and Government Use

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”) announced that it is making its Advantage™ quantum computing systems available for purchase by research centers, academic institutions, and governments, enabling on-premises quantum experimentation and development. D-Wave expects the move, which is highlighted by Forschungszentrum Jülich’s recent acquisition of a D-Wave Advantage system, to drive advanced research and new discoveries in areas such as artificial intelligence (AI) and quantum simulation. The offering includes shipping, installation, calibration, ongoing maintenance, and assistance with local hybrid quantum solver setup. Additionally, D-Wave introduced the "Quantum Uplift" program, offering incentives for organizations dissatisfied with competitor quantum systems. To view the…

WednesdayFeb 12, 2025 12:35 pm

TinyGemsBreaks – Brera Holdings PLC (NASDAQ: BREA) Increases Stake in Juve Stabia to 38.46%

Brera Holdings (NASDAQ: BREA) has completed the third phase of its multi-step acquisition of S.S. Juve Stabia, bringing its ownership stake to 38.46%. The latest closing involved acquiring shares from the holding company of Juve Stabia President Andrea Langella, reinforcing Brera’s commitment to the club. Juve Stabia, currently sixth in Serie B, remains a key part of Brera's global multi-club ownership strategy. Executive Chairman Daniel McClory emphasized the club's strong performance and growth potential. The final closing, expected by March 31, 2025, will bring Brera Holdings' stake to 51.73%. To view the full press release, visit https://ibn.fm/7k0ui About Brera Holdings…

TuesdayFeb 11, 2025 1:57 pm

TinyGemsBreaks – Brera Holdings PLC (NASDAQ: BREA) Strengthens Community Ties with Juve Stabia and Castellammare di Stabia

Brera Holdings (NASDAQ: BREA) is reinforcing its commitment to S.S. Juve Stabia and the City of Castellammare di Stabia through strategic discussions with local leaders. Executive Chairman Daniel McClory met with Mayor Luigi Vicinanza and key stakeholders on Jan. 23 to discuss the club's integration into the community, including proposed renovations to the Romeo Menti Stadium. The meetings also honored former club president Giovanni La Mura and engaged sponsors and commercial partners. Brera Holdings aims to enhance Juve Stabia’s role in social and economic development, fostering long-term success. To view the full press release, visit https://ibn.fm/T2rBg About Brera Holdings PLC…

MondayFeb 10, 2025 3:26 pm

TinyGemsBreaks – Consumer Automotive Finance Inc. (CAFI) Launches Five New Sports Nutrition Products, Provides Update on Corporate Name, Ticker Change

Consumer Automotive Finance (OTC: CAFI), soon to be renamed Fifty 1 Labs, today announced that it has launched five new products in the sports nutrition market. The expansion reinforces 51 Labs' commitment to delivering high-quality, performance-enhancing supplements that support active and health-conscious consumers. In addition, the company provided an update, indicating it is in the final phase of the process for its name and ticker symbol change, marking a significant step forward in its corporate growth strategy. "Our goal at 51 Labs is to continuously innovate and provide our customers with products that enhance their performance, recovery and overall health,"…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

TinyGemsBreaks